Fact CheckerSign in

NCT07206914Not yet recruiting

Geographic Analysis of Cancer Patients' Residences at Delafontaine Hospital

Source: ClinicalTrials.gov · Last updated 3 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study looks at where cancer patients treated at Delafontaine Hospital live and how far they have to travel for care. By mapping patients' home addresses (anonymized), the research will show how distance, transportation, and social factors affect access to cancer treatments and support services. The goal is to better understand inequalities in access to care and to improve patient support in the future.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
26 Sept 2025
Start date
15 Oct 2025
Primary completion date
15 Apr 2026
Lead sponsor
Centre Hospitalier de Saint-Denis
NCT number
NCT07206914

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 15 Oct 2025 to the primary completion date, 15 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • \- Patients whose cancer treatment in the oncology department was completed before 2020.

Who the study is looking for

  • \- Adult patients treated for cancer in the oncology department of Delafontaine Hospital since January 1, 2020.

Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centre Hospitalier de Saint-Denis
Coordinator of this site? Confirm its status
Saint-DenisFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.